Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 2Hot Flashes 2Carcinoma, Intraductal, Noninfiltrating 1Breast Cancer Early Stage Breast Cancer (Stage 1-3) 1

Interventions

Acupuncture Therapy 10Gabapentin 6Venlafaxine Hydrochloride 4Isoflavones 3Estrogens, Conjugated (USP) 3Bupivacaine 3liposomal amphotericin B 2fezolinetant 2black cohosh root extract 2Tamoxifen 2Soybean Proteins 2Sodium Chloride 2Moxifloxacin 2Magnesium Oxide 2Hypnosis 2Control Groups 2Caspofungin 2zopiclone 1oxybutynin 1bazedoxifene 1Zolpidem 1Vitamin B 6 1Vancomycin 1Therapeutics 1Testosterone 1Tazobactam 1Tablets 1Sugars 1Solifenacin Succinate 1Progesterone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Hot Flashes × fezolinetant × Clear all
NCT06440967 2026-04-06

A Study to Confirm if Fezolinetant Helps Reduce Hot Flashes in Women With Breast Cancer Who Are Having Hormone Therapy

Astellas Pharma Inc

Phase 3 Active not recruiting
984 enrolled

Hot Flashes

NCT06972875 2026-02-05

FLASH

University of Vermont

Phase 2 Recruiting
32 enrolled
Genitourinary

Prostatic Neoplasms, Hot Flashes

Data powered by HemOnc (CC BY 4.0) Colophon âš¡